Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Stat-Diagnostica Appoints Vaillant as Chairman of the Board

Premium

Spanish medical diagnostics firm Stat-Diagnostica has appointed Gerard Vaillant as chairman of its board of directors.

Vaillant has held of number of senior executive positions within Johnson & Johnson, including managing director of Ortho Clinical Diagnostics France; vice president of J&J International; worldwide president, LifeScan, a J&J company; and group chairman, diagnostics worldwide. He was also a member of J&J’s Medical Devices and Diagnostic Group Operating Committee until retiring in 2004. After his retirement from J&J, he remained as a board member of both Luminex and Vivacta.

In addition to his current position with Stat-Diagnostica, Vaillant currently serves as chairman of the board of SafeOrthopaedics and PathoQuest; a board member of Tecan; and a venture partner at KLS Partners.

Stat-Diagnostic said that Vaillant "brings expert industry perspective and guidance" to the company as it prepares for the successive European and US launches of its DiagCORE near-patient testing platform (PCR Insider, 5/16/2013)

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.